JPRN-UMIN000003597招募中未知
A prospective, randomized, open-label clinical trial evaluating the effect of sarpogrelate hydrochloride on skin perfusion pressure in hemodialysis patients with arteriosclerosis obliterans - A prospective, randomized, open-label clinical trial evaluating the effect of sarpogrelate hydrochloride on skin perfusion pressure in hemodialysis patients with arteriosclerosis obliterans
Department of Internal Medicine, Tokai University School0 个研究点目标入组 48 人开始时间: 2010年5月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with revascularization 2)Patients who is taking antiplatelet agents excluding low-dose aspirin and/or thienopyridine derivatives 3)Patients with warfarin 4)Patients with coronary artery disease and/or cerebrovascular disease within three months 5)Patients with bleeding or bleeding tendency 6)Patients with severe hepatic dysfunction and/or cardiac dysfunction 7)Patients with malignancy 8)Pregnant or lactating women, or women who wish to become pregnant 9)Patients with allergy to sarpogrelate hydrochloride 10)Patients who were not suitable for this trial judged by the attending doctor
研究者
相似试验
进行中（未招募）
1 期
Clinical Study to assess positive value of blood plasma from donors having built immunity against the new corona virus (SARS-CoV-2) transfused to patients suffering from SARS-CoV-2 infectioEUCTR2020-001310-38-DEDRK-Bluspendedienst Baden-Württemberg - Hessen gGmbH120
进行中（未招募）
1 期
clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged virological suppression.Infection with human immunodeficiency virus (HIV).MedDRA version: 20.1Level: LLTClassification code 10008919Term: Chronic HIV infectionSystem Organ Class: 100000004862EUCTR2015-000274-35-ESFUNDACIÓ CLÍNIC PER A LA RECERCA BIOMÈDICA265
招募中
不适用
Efficacy and patient satisfaction in bowel cleansing protocols using polyethylene glycol-ascorbic acid (PEG) and picolyteKCT0004218Korea University Anam Hospital330
进行中（未招募）
不适用
Study to evaluate if the medication taken for inducing the production of eggs, Follicle Stimulating Hormone (FSH), may induce any kind of immune reaction.EUCTR2012-000269-19-ESIBSA, Institute Biochimique S.A.
进行中（未招募）
1 期
A clinical study conducted in several test centres to investigate the safety and tolerability of a year-round dosage of immune therapy with an Allergoid drug in patients with hay fever and or without controlled asthma.Patients with moderate to severe seasonal rhinitis or rhinoconjunctivitis with or without controlled asthma.MedDRA version: 19.0Level: LLTClassification code 10039776Term: Seasonal allergic rhinitisSystem Organ Class: 100000004870MedDRA version: 19.0Level: LLTClassification code 10001726Term: Allergic rhinitis due to pollenSystem Organ Class: 100000004870MedDRA version: 19.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853MedDRA version: 19.0Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855MedDRA version: 19.0Level: LLTClassification code 10001723Term: Allergic rhinitisSystem Organ Class: 100000004855EUCTR2015-002409-13-DEAllergopharma GmbH & Co. KG240